Literature DB >> 18330731

Interdisciplinary tumour boards in Switzerland: quo vadis?

Kuno Lehmann1, Ulrich Guller, Sophie Bugnon, Markus Zuber.   

Abstract

BACKGROUND/AIMS: The objective of the present investigation is twofold: first, to assess how interdisciplinary tumour boards in Switzerland are designed, established, and rated in clinical practice; and second, to evaluate perceptions regarding the determination of cancer centres as required by the Swiss National Cancer Programme.
METHODS: An anonymous questionnaire was sent to the heads of surgical departments in Switzerland (n = 110). Among the clinics contacted were 11 large referral centres (type A clinics), 48 surgical departments of cantonal hospitals (type B clinics), and 51 regional surgical departments (type C clinics).
RESULTS: For most type A and B clinics, tumour boards are held on a weekly basis (A: 100%, B: 88%, C: 26%). On average, 66% of respondents (A: 90%, B: 71 %, C: 52 %) consider tumour boards a standard of care for every cancer patient. Determination of cancer centres was favoured by 49% of all respondents (A: 80%, B: 56%, C: 32 %).
CONCLUSION: The present survey in Switzerland clearly shows significant differences between type A, B, and C clinics in the use of tumour boards and in their perception as a standard of care. There are wide discrepancies in the perceived need to determine cancer centres in Switzerland as required by the Swiss National Cancer Programme. Since the implementation of tumour boards is associated with optimised cancer patient care, continuing education on their importance is a vital necessity.

Entities:  

Mesh:

Year:  2008        PMID: 18330731     DOI: 2008/09/smw-12078

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  3 in total

1.  Multidisciplinary cancer conferences: exploring obstacles and facilitators to their implementation.

Authors:  Nicole J Look Hong; Anna R Gagliardi; Susan E Bronskill; Lawrence F Paszat; Frances C Wright
Journal:  J Oncol Pract       Date:  2010-03       Impact factor: 3.840

Review 2.  Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa.

Authors:  Clement A Adebamowo; Corey Casper; Kishor Bhatia; Sam M Mbulaiteye; Annie J Sasco; Warren Phipps; Sten H Vermund; Susan E Krown
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

3.  General surgeons' views on Oncologic Multidisciplinary Group meetings as part of colorectal cancer care.

Authors:  Francesco Feroci; Elisa Lenzi; Maddalena Baraghini; Stefano Cantafio; Marco Scatizzi
Journal:  Updates Surg       Date:  2012-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.